RALGAPA2 and breast cancer: Additionally, it was utilised to detect elevated sEV phosphoproteins with a potential diagnostic value such as GTPase-activating protein subunit alpha-2 (RALGAPA2), cGMP-dependent protein kinase1 (PKG1), and tight junction protein 2 (TJP2) in BC patients [145].